3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
8
Myeloproliferative Disorders
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Multiple Myeloma
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphoid
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Blast Crisis
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Precancerous Conditions
2
Interventions
Nivolumab
37
pembrolizumab
30
cabozantinib
27
Specimen Handling
25
Magnetic Resonance Spectroscopy
22
Ipilimumab
20
lenvatinib
16
Axitinib
15
belzutifan
13
CTLA-4 Antigen
10
Sunitinib
9
Biopsy
9
Radiosurgery
8
atezolizumab
7
Immunoglobulin G
5
toripalimab
4
fludarabine
4
avelumab
4
aldesleukin
4
Everolimus
4
Disulfides
4
Cyclophosphamide
4
zimberelimab
3
tivozanib
3
spartalizumab
3
pazopanib
3
palbociclib
3
durvalumab
3
cemiplimab
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Peripheral Blood Stem Cell Transplantation
×
90 days
×
Clear all
No trials found.